US7611521078 - Common Stock
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy ...
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
What's going on in today's session: S&P500 movers
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Investors liked the healthcare technology company's latest quarterly update.
ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips ResMed (NYSE:RMD) just reported results for the third quarter of 2024.ResMed re...
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of...
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the...